10x Genomics announces Atera, a new in situ spatial biology platform

10x Genomics (TXG) announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented scale. “At 10x, our mission is to accelerate the mastery of biology to advance human health,” said Serge Saxonov, Chief Executive Officer and Co-founder of 10x Genomics. “Biology is inherently complex, and as much progress as we have made, we still understand only a fraction of how it works. Progress in medicine depends on confronting that complexity directly, which requires measuring biology as it actually functions: systems of individual cells, expressing specific transcripts, in precise locations within tissue. Atera removes the trade-offs that have constrained research, unlocking a new era of insight that will transform our understanding of science and human health.”